| Grant ID | RR240027 |
| Awarded On | February 21, 2024 |
| Title | Recruitment of First-Time, Tenure-Track Faculty Members |
| Program | CPRIT Scholar |
| Award Mechanism | Recruitment of First-Time, Tenure-Track Faculty Members |
| Institution/Organization | Baylor College of Medicine |
| Principal Investigator/Program Director | Vishnu Dileep |
| Cancer Sites | All Sites |
| Contracted Amount | $2,000,000 |
| Summary of Goals and Objectives |
Chemotherapy-induced cognitive impairment, often referred to as 'chemobrain' or 'chemofog' is a common consequence of cancer treatments, leading to persistent cognitive challenges like memory and attention problems even after treatment ends. Despite its prevalence, there are no effective treatment options. With around 18 million cancer survivors as of 2022, and an expected increase to 26 million by 2040, there is a dire need to develop modalities to treat or prevent chemobrain, which seriously impacts the quality of life. The primary roadblock to developing strategies to prevent or cure chemobrain is a significant lack of understanding about how chemotherapy affects brain cells at a molecul... |